Yes, We Can, But Should We? Ethical Considerations in Reporting Germline Findings From Paired Tumor-Normal Genomic Testing in Patients With Advanced Cancer-Reference-Cited by-同舟云学术

Yes, We Can, But Should We? Ethical Considerations in Reporting Germline Findings From Paired Tumor-Normal Genomic Testing in Patients With Advanced Cancer

Published:2023-04-10 Issue:11 Volume:41 Page:1982-1985
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Hunter Cynthia L.¹²^ORCID,Helft Paul R.³

Affiliation:

1. Indiana University Health Department of Medical and Molecular Genetics, Indianapolis, IN

2. Indiana University Health Precision Genomics, Indianapolis, IN

3. Division of Hematology/Oncology, Department of Medicine, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Charles Warren Fairbanks Center for Medical Ethics, Indiana University Health, Indianapolis, IN

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.22.00796

Reference36 articles.

1. Precision Oncology: Who, How, What, When, and When Not?

2. Clinical cancer genomic profiling

3. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

4. Reporting genomic secondary findings: ACMG members weigh in

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidental pathogenic germline alterations detected through liquid biopsy in patients with solid tumors: prevalence, clinical utility and implications;British Journal of Cancer;2024-03-26

2. Personalized medicine with germline pathogenic variants: Importance of population‐ and region‐wide evidence;Cancer Science;2023-08-02